Resmetirom is an API that acts as a selective agonist of the thyroid hormone receptor beta. It is structurally related to triiodothyronine and is under investigation for use in metabolic dysfunction-associated steatohepatitis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 920509-32-6
Fosphenytoin sodium
pharmaceutical raw material
Phosphocreatine sodium
pharmaceutical raw material
(3R)-3-Methylpiperazin-2-one
pharmaceutical raw material
Ipratropium bromide monohydrate
pharmaceutical raw material
2-[3,5-dichloro-4-[(6-oxo-5-propan-2-yl-1H-pyridazin-3-yl)oxy]phenyl]-3,5-dioxo-1,2,4-triazine-6-carbonitrile
FDBYIYFVSAHJLY-UHFFFAOYSA-N
CC(C)C1=CC(=NNC1=O)OC2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C(=N3)C#N)Cl